BREAKING
Avery Dennison Tops Q1 2026 Profit Forecast With $2.47 EPS 14 seconds ago Why Albemarle Is Dropping 5.9%: RBC Capital Maintains Outperform 4 minutes ago Ichor Holdings Drops 8.9% Amid Sector-Wide Selling 5 minutes ago Vicor Drops 8.2% Amid Sector-Wide Selling 1 hour ago Power Integrations Drops 5.8% Amid Sector-Wide Selling 1 hour ago Itron Drops 5.0% on EPS Beat 1 hour ago Ultra Clean Holdings Drops 7.1% Amid Sector-Wide Selling 1 hour ago Purple Innovation Releases Q1 2026 Financial Results 1 hour ago Asbury Automotive Group Q1 2026 Profit Trails Wall Street Expectations 1 hour ago Crown Holdings Posts 13% Revenue Jump in Q1 2026, Beats on EPS 1 hour ago Avery Dennison Tops Q1 2026 Profit Forecast With $2.47 EPS 14 seconds ago Why Albemarle Is Dropping 5.9%: RBC Capital Maintains Outperform 4 minutes ago Ichor Holdings Drops 8.9% Amid Sector-Wide Selling 5 minutes ago Vicor Drops 8.2% Amid Sector-Wide Selling 1 hour ago Power Integrations Drops 5.8% Amid Sector-Wide Selling 1 hour ago Itron Drops 5.0% on EPS Beat 1 hour ago Ultra Clean Holdings Drops 7.1% Amid Sector-Wide Selling 1 hour ago Purple Innovation Releases Q1 2026 Financial Results 1 hour ago Asbury Automotive Group Q1 2026 Profit Trails Wall Street Expectations 1 hour ago Crown Holdings Posts 13% Revenue Jump in Q1 2026, Beats on EPS 1 hour ago
ADVERTISEMENT
CTMX

CytomX Therapeutics, Inc

$CTMX NASDAQ May 5, 2022 AMC Q1 2022

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

CTMX Coverage

News CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 Mar 16, 2026 News CytomX Therapeutics, Inc. (CTMX) Reports Full Year 2025 Earnings Mar 16, 2026 Event CytomX Therapeutics, Inc (CTMX) Q2 2022 Aug 1, 2022 Event CytomX Therapeutics, Inc (CTMX) Q4 2021 Earnings Conference Call Feb 23, 2022 Event CytomX Therapeutics, Inc (CTMX) CytomX Therapeutics Third Quarter 2021 Financials Conference Call and Webcast Nov 8, 2021